Publication:
SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology

Simple item page
cris.virtualsource.author-orcid07aa27d0-bc80-41d0-81ce-74b6bb5dfa9e
cris.virtualsource.author-orcidb929430d-40d9-4a06-9c32-717e8db50a0a
datacite.rightsopen.access
dc.contributor.authorKamm, Christian Philipp
dc.contributor.authorMattle, Heinrich
dc.date.accessioned2024-10-14T07:53:37Z
dc.date.available2024-10-14T07:53:37Z
dc.date.issued2009
dc.description.abstractStatins have anti-inflammatory and immunomodulatory properties in addition to their lipid-lowering effects. Currently, the effects of statins on multiple sclerosis are still controversial. Therefore, randomized clinical trials are needed to provide better evidence on the therapeutic potential of statins in multiple sclerosis. The SWiss Atorvastatin and Interferon Beta-1b trial in Multiple Sclerosis (SWABIMS) evaluates the efficacy, safety and tolerability of atorvastatin 40 mg per os daily and subcutaneous interferon beta-1b every other day compared to monotherapy with subcutaneous interferon beta-1b every other day in patients with relapsing-remitting multiple sclerosis.
dc.description.numberOfPages7
dc.description.sponsorshipUniversitätsklinik für Neurologie
dc.identifier.doi10.7892/boris.32430
dc.identifier.isi000273286900001
dc.identifier.pmid20003436
dc.identifier.publisherDOI10.1186/1745-6215-10-115
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/105861
dc.language.isoen
dc.publisherBioMed Central
dc.publisher.placeLondon
dc.relation.ispartofTrials
dc.relation.issn1745-6215
dc.relation.organizationDCD5A442BAE0E17DE0405C82790C4DE2
dc.titleSWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.startPage115
oaire.citation.volume10
oairecerif.author.affiliationUniversitätsklinik für Neurologie
oairecerif.author.affiliationUniversitätsklinik für Neurologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.description.ispublishedpub
unibe.eprints.legacyId32430
unibe.journal.abbrevTitleTRIALS
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
1745-6215-10-115.pdf
Size:
329.53 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by/4.0
Content:
published
Download

Collections

Publications